Low Seroprevalence of Neutralizing Antibodies to Adeno-associated Virus Serotype 9 (AAV9) in Preparation for Mypeak-1, the First-in-Human Study of TN-201, an Investigational AAV9-mediated Gene Therapy for Individuals with MYBPC3-associated Hypertrophic Cardiomyopathy (HCM)
Journal of Cardiac Failure（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined